Effect of whole blood storage on factor VIII recovery in fresh frozen plasma and cryoprecipitate

被引:11
作者
Allersma, DP
Imambaks, RMR
Meerhof, LJ
机构
[1] CLB, Amsterdam
[2] CLB, NL 1066 CX Amsterdam
关键词
D O I
10.1046/j.1423-0410.1996.7130150.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Depending on logistics, whole blood has to be stored for several hours after collection. If storage time exceeds 8 h, storage has to be at 1-6 degrees C to comply with FDA regulations. In the Netherlands, however, whole blood is also stored for 12-15 h at 20-24 degrees C using butane-1,4-diol cooling devices. We compared these two storage methods for factor VIII recovery in plasma and cryoprecipitate. At laboratory scale a significantly higher factor VIII recovery was found in plasma prepared from whole blood stored at ambient temperature; in cryoprecipitate this was confirmed but differences were not significant. However, as a result of inefficient cooling in routine procedure, no significantly different factor VIII recoveries were found in plasma prepared from whole blood stored at either of the two temperatures. From our study we conclude that overnight storage of whole blood at ambient temperature using butane-1,4-diol cooling devices has to be favoured.
引用
收藏
页码:150 / 154
页数:5
相关论文
共 11 条
[1]   STUDIES ON THE PROCUREMENT OF BLOOD-COAGULATION FACTOR-VIII - INVITRO STUDIES ON BLOOD COMPONENTS PREPARED IN HALF-STRENGTH CITRATE ANTICOAGULANT 18 HOURS AFTER PHLEBOTOMY [J].
GRIFFIN, B ;
BELL, K ;
PROWSE, C .
VOX SANGUINIS, 1988, 55 (01) :9-13
[2]   EFFECT OF DELAYED BLOOD PROCESSING ON THE YIELD OF FACTOR-VIII IN CRYOPRECIPITATE AND FACTOR-VIII CONCENTRATE [J].
HUGHES, C ;
THOMAS, KB ;
SCHIFF, P ;
HERRINGTON, RW ;
POLACSEK, EE ;
MCGRATH, KM .
TRANSFUSION, 1988, 28 (06) :566-570
[3]   BACTERIAL-CONTAMINATION OF SINGLE-DONOR BLOOD COMPONENTS [J].
ILLERT, WE ;
SANGER, W ;
WEISE, W .
TRANSFUSION MEDICINE, 1995, 5 (01) :57-61
[4]   STORAGE OF WHOLE-BLOOD FOR UP TO 24 HOURS AT AMBIENT-TEMPERATURE PRIOR TO COMPONENT PREPARATION [J].
PIETERSZ, RNI ;
DEKORTE, D ;
REESINK, HW ;
DEKKER, WJA ;
VANDENENDE, A ;
LOOS, JA .
VOX SANGUINIS, 1989, 56 (03) :145-150
[5]   PREVENTION OF YERSINIA-ENTEROCOLITICA GROWTH IN RED-BLOOD-CELL CONCENTRATES [J].
PIETERSZ, RNI ;
REESINK, HW ;
PAUW, W ;
DEKKER, WJA ;
BUISMAN, L .
LANCET, 1992, 340 (8822) :755-756
[6]   EFFECT OF TEMPERATURE-VARIATIONS ON CRYOPRECIPITATE [J].
ROCK, GA ;
TITTLEY, P .
TRANSFUSION, 1979, 19 (01) :86-89
[7]  
SAZAMA K, 1994, ARCH PATHOL LAB MED, V118, P350
[8]   INACTIVATION OF FACTOR 8 IN-VITRO [J].
STIBBE, J ;
HEMKER, HC ;
CREVELD, SV .
THROMBOSIS ET DIATHESIS HAEMORRHAGICA, 1972, 27 (01) :43-&
[9]   CONTRIBUTIONS TO OPTIMAL USE OF HUMAN-BLOOD .8. STABILITY OF BLOOD-COAGULATION FACTOR-8 DURING COLLECTION AND STORAGE OF WHOLE-BLOOD AND PLASMA [J].
VERMEER, C ;
SOUTE, BAM ;
ATES, G ;
HELLINGS, JA ;
BRUMMELHUIS, HGJ .
VOX SANGUINIS, 1976, 31 :55-67
[10]   CONTRIBUTIONS TO OPTIMAL USE OF HUMAN-BLOOD .7. INCREASE OF YIELD OF FACTOR 8 IN 4-DONOR CRYOPRECIPITATE BY AN IMPROVED PROCESSING OF BLOOD AND PLASMA [J].
VERMEER, C ;
SOUTE, BAM ;
ATES, G ;
BRUMMELHUIS, HGJ .
VOX SANGUINIS, 1976, 30 (01) :1-22